Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lane

Showing results (641-650 of 703) with videos related to

Pageof 71
Sort By:
The Journal of Infectious Diseases|July 1, 1996
Inhibition of immunoreactive tumor necrosis factor-alpha by a chimeric antibody in patients infected with human immunodeficiency virus type 1R E Walker, K M Spooner, G Kelly, et al.
Infection and Immunity|April 20, 2021
Dynamic Pneumococcal Genetic Adaptations Support Bacterial Growth and Inflammation during Coinfection with InfluenzaAmanda P Smith, Lindey C Lane, Tim van Opijnen, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 29, 2019
Loss of endothelial sulfatase-1 after experimental sepsis attenuates subsequent pulmonary inflammatory responsesKaori Oshima, Xiaorui Han, Yilan Ouyang, et al.
Zoonoses and Public Health|May 22, 2015
A Multistate Investigation of Antibiotic-Resistant Salmonella enterica Serotype I 4,[5],12:i:- Infections as Part of an International Outbreak Associated with Frozen Feeder RodentsE J Cartwright, T Nguyen, C Melluso, et al.
The Journal of Infectious Diseases|April 1, 1996
Combination therapy with didanosine and interferon-alpha in human immunodeficiency virus-infected patients: results of a phase I/II trialJ A Kovacs, C Bechtel, R T Davey, et al.
Pediatric Nephrology (Berlin, Germany)|October 4, 2011
Prevalence of sleep disturbances in children and adolescents with chronic kidney diseaseIra D Davis, Larry A Greenbaum, Debbie Gipson, et al.
Leukemia|December 20, 2023
Chemical genetic control of cytokine signaling in CAR-T cells using lenalidomide-controlled membrane-bound degradable IL-7Michael C Kann, Emily M Schneider, Antonio J Almazan, et al.
The Journal of Infectious Diseases|September 9, 2000
Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expressionJ A Kovacs, H Imamichi, S Vogel, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1997
Clarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infectionM A Polis, S C Piscitelli, S Vogel, et al.
The Journal of Infectious Diseases|May 24, 2000
A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell counts >/=350/mm3M H Losso, W H Belloso, S Emery, et al.
Pageof 71

Showing results (641-650 of 703) with videos related to

Sort By:
Pageof 71
The Journal of Infectious Diseases|July 1, 1996
Inhibition of immunoreactive tumor necrosis factor-alpha by a chimeric antibody in patients infected with human immunodeficiency virus type 1R E Walker, K M Spooner, G Kelly, et al.
Infection and Immunity|April 20, 2021
Dynamic Pneumococcal Genetic Adaptations Support Bacterial Growth and Inflammation during Coinfection with InfluenzaAmanda P Smith, Lindey C Lane, Tim van Opijnen, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 29, 2019
Loss of endothelial sulfatase-1 after experimental sepsis attenuates subsequent pulmonary inflammatory responsesKaori Oshima, Xiaorui Han, Yilan Ouyang, et al.
Zoonoses and Public Health|May 22, 2015
A Multistate Investigation of Antibiotic-Resistant Salmonella enterica Serotype I 4,[5],12:i:- Infections as Part of an International Outbreak Associated with Frozen Feeder RodentsE J Cartwright, T Nguyen, C Melluso, et al.
The Journal of Infectious Diseases|April 1, 1996
Combination therapy with didanosine and interferon-alpha in human immunodeficiency virus-infected patients: results of a phase I/II trialJ A Kovacs, C Bechtel, R T Davey, et al.
Pediatric Nephrology (Berlin, Germany)|October 4, 2011
Prevalence of sleep disturbances in children and adolescents with chronic kidney diseaseIra D Davis, Larry A Greenbaum, Debbie Gipson, et al.
Leukemia|December 20, 2023
Chemical genetic control of cytokine signaling in CAR-T cells using lenalidomide-controlled membrane-bound degradable IL-7Michael C Kann, Emily M Schneider, Antonio J Almazan, et al.
The Journal of Infectious Diseases|September 9, 2000
Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expressionJ A Kovacs, H Imamichi, S Vogel, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1997
Clarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infectionM A Polis, S C Piscitelli, S Vogel, et al.
The Journal of Infectious Diseases|May 24, 2000
A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell counts >/=350/mm3M H Losso, W H Belloso, S Emery, et al.
Pageof 71